RMAT Designation Requests May Rise Or Fall On Manufacturing Changes, Clinical Data Breadth

 
• By Sue Sutter
Yes no maybe Button over white Background
Whether FDA says 'yes' or 'no' to an RMAT designation request may depend upon changes to the product during development and the extent of clinical data provided on different outcomes.

More from Cell & Gene Therapies

More from Advanced Technologies